Among them, the PTPH1 specifically catalyzes EGFR/Y1173 dephosphorylation (and not EGFR/Y1068 dephosphorylation), thus finally increasing non-TNBC BC sensitivity to TKIs, including GEF37. The gene discussed is PTPN3; the disease is breast cancer.